Fmoc-AEEAc-OH CAS 166108-71-0 Assay ≥99.0% (HPLC)
Shanghai Ruifu Chemical is the leading manufacturer of Fmoc-AEEAc-OH (CAS: 166108-71-0) with high quality.
Ruifu Chemical can provide worldwide delivery, competitive price, excellent service.
Purchase Fmoc-AEEAc-OH or other products, please contact us by e-mail: alvin@ruifuchem.com
| Chemical Name | Fmoc-AEEAc-OH |
| Synonyms | {2-[2-(Fmoc-amino)ethoxy]ethoxy}acetic Acid; 8-(Fmoc-amino)-3,6-Dioxa-n-Octanoic Acid; Fmoc-8-Amino-3,6-Dioxaoctanoic Acid; Fmoc-NH-PEG2-CH2COOH; 8-[(9H-Fluoren-9-ylmethoxy)carbonylamino]-3,6-Dioxa-n-Octanoic Acid; [2-[2-[(9H-Fluoren-9-ylmethoxy)carbonylamino]ethoxy] ethoxy]acetic Acid; Fmoc-AEEA-OH; |
| Stock Status | In Stock, Production Capacity More than 100kg |
| CAS Number | 166108-71-0 |
| Molecular Formula | C21H23NO6 |
| Molecular Weight | 385.42 g/mol |
| Melting Point | 90.0-92.0℃ |
| Density | 1.265±0.06 g/cm3 |
| Store Under Inert Gas | Store Under Inert Gas |
| Sensitive | Air Sensitive |
| Storage Temperature | Store Long-Term at 2-8℃ |
| COA & MSDS | Available |
| Origin of Product | Shanghai, China |
| Product Categories | PEG Linkers / Fmoc-PEG |
| Brand | Ruifu Chemical |
| Items | Specifications | Results |
| Appearance | White Crystalline Powder | White Crystalline Powder |
| Loss on Drying | ≤0.50% | 0.20% |
| Related Substances | ||
| Any Impurity | ≤0.50% | Conforms |
| Sum of Impurities | ≤2.00% | Conforms |
| Assay / Analysis Method | ≥99.0% (HPLC) (On Anhydrous Basis) | 99.31% |
| 400MHz 1H | Consistent with Structure | Conforms |
| LCMS | Consistent with Structure | Conforms |
| Conclusion | The product has been tested and complies with the given specifications | |
Package: Bottle, Aluminium foil bag, 25kg/cardboard drum, double PE bags inside.
Storage Condition: Keep the container tightly closed. Store in a cool, dry (2-8℃) and well-ventilated warehouse away from incompatible substances. Keep away from sunshine; avoid fire and heat sources; avoid moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery.
How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Safety Description S22 - Do not breathe dust.
S24/25 - Avoid contact with skin and eyes.
WGK Germany 3
Fmoc-AEEAc-OH (CAS: 166108-71-0) is a PEG linker containing an Fmoc-protected amine and a terminal carboxylic acid. The hydrophilic PEG spacer increases solubility in aqueous media. The Fmoc group can be deprotected under basic condition to obtain the free amine which can be used for further conjugations. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond.
Fmoc-AEEAc-OH offers potential in various applications, including pharmaceutical development and drug discovery research, peptide synthesis, and bioconjugation strategies.
